Pneumonia vaccine study for children with severe malnutrition
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether giving a pneumococcal vaccine to children hospitalized with severe acute malnutrition can help prevent serious infections. It aims to see if the vaccine is safe and effective in this vulnerable group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 6 months and 5 years old
- Your child is hospitalized because of severe malnutrition (very low weight for height, or a mid-upper arm circumference less than 11.5 cm, or swelling in both feet and ankles)
- You agree to your child taking part and follow all study procedures, including blood tests
- Your child has not taken part in this study before, and has not used other investigational medications in the past 30 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new pneumonia vaccine (PCV13) in healthy infants to see if it works as well as a current vaccine. It compares the immune response and safety of the two vaccines.
This trial tests a new 23-valent pneumococcal vaccine to see if it safely protects healthy people against pneumonia and other infections caused by pneumococcal bacteria.
This trial tests a catch-up pneumococcal vaccine for children and adolescents who may have missed some doses. It aims to see how safe and effective the vaccine is in healthy kids aged 15 months to 17 years.
This study tests a new vaccine to protect infants from pneumococcal disease (a serious bacterial infection). Researchers want to see how well the vaccine works and how safe it is in healthy babies aged 2–6 months.
This study tests whether a new pneumococcal vaccine (which protects against a serious bacterial infection) is safe in healthy 2-month-old infants. Researchers will watch for side effects and help protect future babies from pneumococcal disease.
This trial tests whether a pneumococcal vaccine can help protect against a specific type of pneumonia bacteria. Researchers want to see if the vaccine can create antibodies that work against multiple strains.
Hear when a new Severe Acute Malnutrition in Childhood trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.